Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar. mfm [Internet]. 2024 May 2 [cited 2025 Nov. 17];26(3). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/2736